Lantheus Holdings (LNTH) Deferred Taxes (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Deferred Taxes of $19.3 million for Q1 2026, up 1330.57% year-over-year from $1.4 million in Q1 2025, and up 1183.35% quarter-over-quarter from -$1.8 million in Q4 2025.
Lantheus Holdings (LNTH) Deferred Taxes (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Deferred Taxes for 12 consecutive years, with $19.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes rose 1330.57% year-over-year to $19.3 million; the TTM figure through Mar 2026 stood at $39.6 million (up 199.08% YoY), while the FY2025 annual figure was $21.6 million, up 171.91% from the prior year.
- Deferred Taxes improved to $19.3 million in Q1 2026 per LNTH's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $29.0 million in Q3 2025 and bottomed at -$62.5 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$5.5 million across 5 years, with a median of -$1.8 million in 2025.
- Annual changes were most pronounced in 2022 — Deferred Taxes sank 1932.71% — and 2026, when it soared 1330.57%.
- Lantheus Holdings' Deferred Taxes stood at -$62.5 million in 2022, then jumped by 103.23% to $2.0 million in 2023, then sank by 1370.55% to -$25.6 million in 2024, then jumped by 93.04% to -$1.8 million in 2025, then surged by 1183.35% to $19.3 million in 2026.
- Business Quant data shows LNTH's Deferred Taxes at $19.3 million in Q1 2026, -$1.8 million in Q4 2025, and $29.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | -13.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.07 Mn |
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | -1.78 Mn |
| Sep 30, 2025 | 28.96 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | -25.63 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | -18.89 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | -18.03 Mn |
| Jun 30, 2023 | -3.75 Mn |
| Mar 31, 2023 | -35.86 Mn |
| Dec 31, 2022 | -62.48 Mn |
| Sep 30, 2022 | 7.86 Mn |
| Jun 30, 2022 | -7.58 Mn |
| Mar 31, 2022 | 14.18 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | -1.66 Mn |